19 As a result, in recent years, there has been a slight trend towards moving trials to the first line, where the abovementioned aspects are believed to be less pronounced.
← all excerpts
Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation.
1
—
—